Home MarketKrebs Biochemicals & Industries Ltd.

Krebs Biochemicals & Industries Ltd. Stock Info: As on 2018-05-24 15:43:06

Nse

166.15

0.15(0.09%)
Change%
52 Week Range
86.00
25.00
211.50
9.00
Open160.10
Day's Range157.70 - 174.30
Value Traded (in ₹ Cr.) 0.01

Bse

172.00

6.00(3.61%)
Change %
52 Week Range
85.80
25.00
209.60
9.00
Open165.00
Day's Range157.70 - 174.30
Value Traded (in ₹ Cr.) 0.07

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 8,214,341.00 59.77%
Mutual Funds/UTI 0.00 0.00%
FII 1,300.00 0.01%
Employee 0.00 0.00%
Public 3,214,798.00 23.39%
Government 0.00 0.00%
Others 2,313,325.00 16.83%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 38.99
Basic EPS (Rs.) -8.39
Cash EPS -8.60
BVPerShare Excl 1.07
Operating Revenue 2.57
PBDITPerShare -5.76
Dividend 0.00
NPPerShare -11.68
Current Ratio 0.41
Quick Ratio 0.24
PriceToBV 93.25
Earnings -0.11
PBDIT Margin -224.48
PBT Margin -454.62
NP Margin -454.62
Return On Assets -13.14
Retention Ratios 0.00
Parameter Mar-17 (₹ Cr.) Yoy%change
Total Income 3.61
Total Expenses 19.25
EBITDA -7.92
PBT -16.05
PAT -16.05
Net Income -16.05
More
Parameter Sep-17 (₹ Cr.) 6M % change
Total Income 4.20
Total Expenses 12.46
EBITDA -10.30
PBT -10.79
PAT -10.79
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-17 (₹ Cr.) Yoy%change
Total share capital 13.74
Net worth 1.48
Investments 0.00
Total Liability 122.08
Total debt 42.79
Net block 105.68
Total Assets 122.08
Parameter Sep-17 (₹ Cr.) 6M % change
Total share capital 12.41
Net worth 7.74
Investments 0.00
Total Liability 107.01
Total debt 65.65
Net block 59.15
Total Assets 107.01
Company Curr Price Prev. Close Change% W's Low/High

Aarti Drugs Ltd.

533.05 531.95 0.21
524.95580

Abbott India Ltd.

6671.7 6587.45 1.28
65106890

Ajanta Pharma Ltd.

977.6 987 -0.95
962.351074.5

Albert David Ltd.

362.35 362.75 -0.11
356.2383.15

Alembic Ltd.

48.85 50.8 -3.84
50.254

Alembic Pharmaceuticals Ltd.

420.7 422.3 -0.38
418.5491.2

Alkem Laboratories Ltd.

1957.55 1965.35 -0.4
18882036.65
Company Curr Price Prev. Close Change% W's Low/High

Aarey Drugs & Pharmaceuticals Ltd.

47.5 49.05 -3.16
46.351.55

Aarti Drugs Ltd.

530 529.15 0.16
526585

Aayush Food & Herbs Ltd.

47.7 48.1 -0.83
4355

Abbott India Ltd.

6699.95 6593.7 1.61
6465.056872.5

ABL Bio-Technologies Ltd.

0.81 0.78 3.85
0.750.81

Addlife Pharma Ltd.

0.46 0 0
0.460.5

Adinath Bio-Labs Ltd.

0.3 0.31 -3.23
0.30.3
More
Parameter Mar-17(in ₹ Cr.)
Cash from operating activities -11.20
Cash from investing activities -4.70
Cash from financing activities 15.75
Net change in cash -0.15

Stock Held By Mutual Fund Schemes

Corporate Details

About Management

YEAR EVENTS 1992 - The Company was incorporated on 8th May, with the purpose of implementing a 100% EOU project to manufacture pseudoephedrine with an annual capacity of 60 TPA. It was promoted by Dr. R.T. Ravi, a technocrat and his associates. - The Company entered into an agreement for obtaining technology/process known-how from CDRI and a technical know-how fee of Rs 10 lakhs and a royalty of Rs 5 lakhs per year for 5 years from the date of commencement of commercial production was payable to CDRI. 1994 - Drug licence was obtained in July and exports commenced. - During March 1994, the Company and through a prospectus 3,800,300 No. of equity shares of Rs 10 each of which the following were issued and allotted: (1) 800,300 shares to promoters, their friends, (2) 500,000 shares to APIDC, (3) 450,000 shares to Second India Investment Fund of ANZ Grindlays Bank. Of the remaining, 200,000 shares issued to ICICI and balance 1,850,000 shares to the public. 1996 - The Operations were affected by cyclone with snapping ST power lines, diesel storage etc. - The Company undertook to set up a new project to produce Monosodium Glutamate (MSG) at a cost of Rs 26.50 crores at Kolhapalli village, Kasimkota Mandal, Visakhapatanam, Andhra Pradesh. - The Company proposed to issue 14,00,000 warrants to the core promoter viz. Dr. R. T. Ravi and family and their associates/nominees and M/s. Ganes Chemicals Inc., U.S.A. and/or their nominees, subject to necessary approvals. 1997 - The new ETP facility at Regadichilak was commissioned at a cost Rs 215 lakhs. - Krebs Biochemicals Ltd. (KBL), which is setting up a new project to produce monosodium glutamate (MSG) with an installed capacity of 5,000 tonnes per annum at a capital outlay of Rs.26.50 crores. 1998 - The company began with an initial capacity of 100,000 tpa and expanded it to 150,000 tpa in 1996. - The company is of the view that the proposed MSG project would now be economically unviable in view of the prevailing currency crisis in the South-East Asian countries. - KBL is currently setting up a 5,000 tonnes per annum MSG project at a cost of Rs.26.5 crores. 1999 - KREBS Biochemicals Ltd (KBL) has registered a fall both in sales turnover and post-tax profit for the year ended March 31, 1999. 2002 -Krebs Biochemicals have recommended dividend @ 75% 2003 -Krebs receives FDA approval for two drugs -Krebs Biochemicals receives approval for 3 APIs 2004 -KBC & ASL in pact withWest Godavari Cooperative Sugar Factory Ltd -Krebs Biochemicals takes over Possession of Assets of Sugar Mill in Jampani, AP 2005 -The company has recommended dividend @ 30% 2007 -Krebs Biochemicals has designed E-mail ID for Investor Complaints: Inv_complnt@krebsbiochem.com 2009 --Registered Office of the Company has been shifted to 8-2-277/A, Plot No.130 , 4A, 4th Floor, Inwinex Towers, Road no.2, Banjara Hills, Hyderabad - 500034 2014 -Transfer agents of the Company has been changed from "Sathguru Management Consultants Pvt. Ltd" to "Karvy Computershare Pvt. Ltd". -Mr. R.Ch. Satyanarayana has been appointed as Independent Director on the Board. 2016 - The company has shifted its registered office from Plot No.34, 8-2-577/B, 3rd Floor, Maas Heights, Road No.8, Banjara Hills, Hyderabad, Telangana- 500034 to Kothapalli Village, Kasimkota Mandal, Anakapalli, Vishakapatnam, Andhra Pradesh- 531031,” the company said in a filing to the Bombay Stock Exchange.

Registered Office

Plot No.34, 8-2-577/B, 3rd Floor, Maas Heights, Road No.8, Banjara Hills,

040-66808040,,,      040-66037755,

investors@krebsbiochem.com

http://www.krebsbiochem.com

Registrar Details

Karvy Computershare Private Ltd.